Provectus Biopharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
PVCT
US74373P1084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Apr. 16 | Provectus Biopharmaceuticals, Inc. Appoints Dominic Rodrigues as President | CI |
Apr. 16 | Provectus Biopharmaceuticals, Inc. Appoints Ed Pershing as Chief Executive Officer | CI |
Financials (USD)
Sales 2022 | 0.99 | Sales 2023 | 0.56 | Capitalization | 40.27M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | 48,121,944 x |
Net Debt 2022 | 2.16M | Net Debt 2023 | 2.95M | EV / Sales 2023 | 77,502,175 x |
P/E ratio 2022 |
-12.8
x | P/E ratio 2023 |
-13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 71 | 18-04-26 |
Eric A. Wachter
FOU | Founder | 61 | 01-12-31 |
Heather Raines
DFI | Director of Finance/CFO | 58 | 17-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric A. Wachter
FOU | Founder | 61 | 01-12-31 |
John W. Lacey
BRD | Director/Board Member | 76 | 18-04-26 |
President | 55 | 17-04-02 |
1st Jan change | Capi. | |
---|---|---|
-2.49% | 102B | |
+2.20% | 96.07B | |
-1.37% | 21.66B | |
-17.06% | 20.77B | |
-7.01% | 18.53B | |
-40.31% | 16.91B | |
-28.21% | 13.79B | |
+0.17% | 13.33B | |
+20.64% | 10.94B |
- Stock Market
- Equities
- PVCT Stock
- PVCT Stock